THE COST OF INFLUENZA IN THE EMERGENCY ROOM AND HOSPITAL

Author(s)

Cox FM1, Okamoto LJ2, Cobb MM1, Chua WQ1, 1Glaxo Wellcome, Research Triangle Park, NC, USA; 2NDC Health Information Services, Phoenix, AZ, USA

Influenza is a common disease that is often perceived as self-limiting and mainly treated at home. However, for a portion of influenza suffers the disease may warrant a visit to the emergency room (ER) or hospitalization. OBJECTIVE: The purpose of this study is to estimate the resources consumed and associated costs of treating influenza patients in the ER and hospital. METHODS: Patient-level clinic and cost data were measured for the study population identified in the Premier Decision Support Services (DSS) databases. Data were analyzed retrospectively from January 1, 1997 to June 30, 1998 for patients with a diagnosis code for influenza using International Classification of Diseases, Ninth Revision-Clinical Modification (ICD-9) coding. Individual medication data were collected for a subset of the subjects in 1997 and all subjects in 1998. Data were summarized using means (±Standard Error) and multivariate analyses of variance (?=0.05) were performed to determine if observed differences in mean costs across demographic variables were statistically significant. RESULTS: Of the 1362 patients who met inclusion criteria, 333 (24.4%) required an inpatient hospital stay for influenza. The average total cost and charge per patient for ER only visits were approximately $142 and $218, respectively. The average total cost and charge per hospitalized patient were approximately $3251 and $5938, respectively. Other cost and demographic data are further detailed in the study. CONCLUSION: Influenza is not a benign disease. For some infected patients, ER or hospital care is needed. More aggressive and effective prevention and treatment strategies may lead to cost avoidance via fewer influenza related ER visits and hospitalizations.

Conference/Value in Health Info

1999-05, ISPOR 1999, Arlington, VA, USA

Value in Health, Vol. 2, No. 3 (May/June 1999)

Code

PID18

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Infectious Disease (non-vaccine)

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×